Development of a Multipurpose Dataset to Evaluate Potential Medication Errors in Ambulatory Settings
暂无分享,去创建一个
[1] Stephen A. Goldman,et al. MEDWATCH THE CLINICAL IMPACT OF ADVERSE EVENT REPORTING , .
[2] R. Davis,et al. The Vaccine Safety Datalink: immunization research in health maintenance organizations in the USA. , 2000, Bulletin of the World Health Organization.
[3] C. Marano,et al. To err is human. Building a safer health system , 2005 .
[4] J. McCulloch,et al. CHAPTER 7 – Implications for Prevention , 1972 .
[5] N. Laird,et al. Incidence of adverse drug events and potential adverse drug events , 1995 .
[6] E H Wagner,et al. A chronic disease score from automated pharmacy data. , 1992, Journal of clinical epidemiology.
[7] S D Small,et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. , 1995, JAMA.
[8] L. Kohn,et al. To Err Is Human : Building a Safer Health System , 2007 .
[9] C. Mackenzie,et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.
[10] C. A. West. National Wholesale Druggists' Association , 1914 .
[11] Jarvis T. Chen,et al. Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter?: the Public Health Disparities Geocoding Project. , 2002, American journal of epidemiology.
[12] N. Laird,et al. Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention , 1995 .